| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBRC.2004.04.099 |
| P698 | PubMed publication ID | 15147950 |
| P2093 | author name string | Noritaka Adachi | |
| Sairei So | |||
| Hideki Koyama | |||
| Susumu Iiizumi | |||
| P433 | issue | 4 | |
| P921 | main subject | DNA damage | Q5205747 |
| P304 | page(s) | 856-861 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage | |
| P478 | volume | 318 |
| Q27938059 | A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin. |
| Q39810024 | BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells. |
| Q38868863 | Catalytic and non-catalytic roles of DNA polymerase κ in the protection of human cells against genotoxic stresses. |
| Q53598952 | Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1. |
| Q24808909 | Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells |
| Q26744712 | Collision of Trapped Topoisomerase 2 with Transcription and Replication: Generation and Repair of DNA Double-Strand Breaks with 5' Adducts |
| Q42704196 | CtIP and MRN promote non-homologous end-joining of etoposide-induced DNA double-strand breaks in G1. |
| Q53232203 | DNA topoisomerase 2 mutant allele mildly delays the mitotic progression and activates the checkpoint protein kinase Chk1 in fission yeast Schizosaccharomyces pombe. |
| Q38561332 | Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. |
| Q48319158 | Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status |
| Q34362544 | Genetic interactions between BLM and DNA ligase IV in human cells |
| Q36425680 | MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA. |
| Q40105785 | NHEJ-deficient DT40 cells have increased levels of immunoglobulin gene conversion: evidence for a double strand break intermediate |
| Q40075000 | NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform. |
| Q34459467 | NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells |
| Q38194755 | Non-homologous end joining often uses microhomology: implications for alternative end joining |
| Q38746745 | Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer. |
| Q24649711 | Targeting DNA topoisomerase II in cancer chemotherapy |
| Q36955793 | The SAGA Deubiquitination Module Promotes DNA Repair and Class Switch Recombination through ATM and DNAPK-Mediated γH2AX Formation. |
| Q34189234 | The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies |
| Q42945997 | The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes |
| Q28475376 | Topoisomerase II-Mediated DNA Damage Is Differently Repaired during the Cell Cycle by Non-Homologous End Joining and Homologous Recombination |
| Q41130676 | Topoisomerase IIalpha-dependent induction of a persistent DNA damage response in response to transient etoposide exposure. |
| Q50130215 | UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4. |
| Q37021622 | WRN protects against topo I but not topo II inhibitors by preventing DNA break formation |
Search more.